Clinical & Translational Oncology

Papers
(The TQCC of Clinical & Translational Oncology is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
GEIS-SEHOP clinical practice guidelines for the treatment of rhabdomyosarcoma105
Immunotherapy in AML: a brief review on emerging strategies75
Exosome-mediated delivery of SCD-1 siRNA promoted the death of anaplastic thyroid carcinoma cells via regulating ROS level50
Over-activation of EFTUD2 correlates with tumor propagation and poor survival outcomes in hepatocellular carcinoma49
Correction to: Comprehensive study for BRCA1 and BRCA2 entire coding regions in breast cancer48
Benefits of early salvage therapy on oncological outcomes in high-risk prostate cancer with persistent PSA after radical prostatectomy47
IFN-γ inhibits ovarian cancer progression via SOCS1/JAK/STAT signaling pathway39
Long noncoding RNA MGC27382 inhibits proliferation and metastasis of non-small cell lung cancer cells via down-regulating AKT/GSK3β pathway32
microRNA-377-3p inhibits osteosarcoma progression by targeting CUL1 and regulating Wnt/β-catenin signaling pathway32
Mechanisms of regulating NIS transport to the cell membrane and redifferentiation therapy in thyroid cancer28
Clinical nutrition as part of the treatment pathway of pancreatic cancer patients: an expert consensus23
SEOR SBRT-SG stereotactic body radiation therapy consensus guidelines for non-spine bone metastasis22
MiR-493-5p inhibits the malignant development of gliomas via suppressing E2F3-mediated dysfunctions of P53 and PI3K/AKT pathways21
A novel 12-gene signature as independent prognostic model in stage IA and IB lung squamous cell carcinoma patients21
Quality indicators and excellence requirements for a multidisciplinary lung cancer tumor board by the Spanish Lung Cancer Group19
The TRIM proteins in cancer: from expression to emerging regulatory mechanisms19
Circular RNA circHIPK3 modulates prostate cancer progression via targeting miR-448/MTDH signaling19
Circulating exosomal miRNAs and cancer early diagnosis17
Short-course radiotherapy in stage IV rectal cancer with resectable disease17
Traditional Chinese medicine reverses cancer multidrug resistance and its mechanism16
MicroRNA-802 promotes the progression of osteosarcoma through targeting p27 and activating PI3K/AKT pathway16
Physio-pathological effects of m6A modification and its potential contribution to melanoma15
Stereotactic radiosurgery with immunotherapy is associated with improved overall survival in patients with metastatic melanoma or non-small cell lung cancer: a National Cancer Database analysis14
The role of radiotherapy for pancreatic malignancies: a population-based analysis of the SEER database14
PD1/PDL1 expression is associated with increased TIM3 expression and tumor-infiltrating T lymphocytes in fibroblastic tumors14
Predictive value of transcriptional expression of Krüppel-like factor-6 (KLF6) in head and neck carcinoma patients treated with radiotherapy14
Human umbilical cord mesenchymal stem cell-derived exosomes carrying hsa-miRNA-128-3p suppress pancreatic ductal cell carcinoma by inhibiting Galectin-314
0.039587020874023